Presentation TCT 2024 TCT 650: Independent Predictors of 2-Year Mortality in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement Presenter: Vincent Lipari October 30, 2024
Presentation TCT 2024 TCT 649: Mortality Is Lowest in Overweight Followed by Obese and Morbid Obese Patients and Is Highest in Cachexia Compared to Normal Weight in Patients With a Diagnosis of Aortic Stenosis Presenter: Mohammad Reza Movahed October 30, 2024
Presentation TCT 2024 TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement Presenter: Constantijn Venema October 30, 2024
Presentation TCT 2024 TCT 647: A Novel Functional Index - Aortic Valve Coefficient (AVC) - For Assessing Low Flow-Low Gradient Aortic Valve Stenosis: A Prospective Study in Patients Undergoing TAVR Presenter: Rishi Sukhija October 30, 2024
Presentation TCT 2024 TCT 646: The Aortic Valve Coefficient (AVC) Cut-off Values for Improved Assessment of Aortic Stenosis Severity: A Prospective Study Presenter: Rupak Banerjee October 30, 2024
Presentation TCT 2024 TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades Presenter: Zaid Abdulelah October 30, 2024
Presentation TCT 2024 The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes Presenter: David Wood October 30, 2024
Presentation TCT 2024 Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program! Presenter: Brian Lindman October 30, 2024
Presentation TCT 2024 Can AI-Assisted Earlier AS Diagnosis Level the Disparities Playing Field? Presenter: Pierre Elias October 30, 2024
Presentation TCT 2024 TCT 799: Unveiling Demographic Disparities in Aortic Stenosis Mortality: An Analysis of Trends and Data Gaps in the United States Presenter: Mobeen Haider October 30, 2024
Presentation TCT 2024 The Emerging Use of TAVR in Younger Patients: Updates and Evidence Gaps Presenter: Harold Dauerman October 30, 2024
Presentation TCT 2024 Surgical Valve Selection in Younger Patients with AS: Mechanical, Bioprosthetic, or Ross? Presenter: Katherine Harrington October 30, 2024
Presentation TCT 2024 Patient Perspectives and Shared Decision-Making in Younger Patients Requiring AS Therapy Presenter: Megan Coylewright October 30, 2024
Presentation TCT 2024 Lessons From the Moderate AS + HF Trial (TAVR UNLOAD) Presenter: Nicolas Van Mieghem October 30, 2024
Presentation TCT 2024 TCT 798: Echocardiographic Left Ventricular Geometry Patterns and Their Progression in Men vs. Women With Moderate Aortic Stenosis Presenter: Kyriakos Panaou October 30, 2024
Presentation TCT 2024 Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR) Presenter: Allan Schwartz October 30, 2024
Presentation TCT 2024 Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED) Presenter: Mark Dweck October 30, 2024
Presentation TCT 2024 Screening for Undiagnosed Aortic Stenosis in Health System EHRs Using ECG-based AI Detection Model (AccurKardia) Presenter: Moin Hussaini October 30, 2024
Presentation TCT 2024 Keynote Lecture II: Master Clinician Perspectives: How Will the Recent Evidence Impact Guidelines and Clinical Practice? Presenter: Patrick O'Gara October 30, 2024
Presentation TCT 2024 Keynote Lecture I: Rationale for Earlier Intervention in Aortic Stenosis: The Cardiac Damage Concept and Beyond Presenter: Philippe Genereux October 30, 2024